ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,882, issued on March 24, was assigned to Mireca Medicines GmbH (Tubingen, Germany).
"Equatorially modified polymer linked multimers of guansine-3', 5'-cyclic monophosphates" was invented by Hans-Gottfried Genieser (Lemwerder, Germany), Frank Schwede (Bremen, Germany), Andreas Rentsch (Bremen, Germany), Per Ekstrom (Lund, Sweden), Valeria Marigo (Modena, Italy) and Francois Paquet-Durand (Tubingen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the invention are directed to new equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphate (cGMP) analogues that inhibit the cGMP-signaling system. The in...